The TNF receptor-ligands 4-1BB-4-1BBL and GITR-GITRL in NK cell responses

The TNF receptor-ligands 4-1BB-4-1BBL and GITR-GITRL in NK cell responses

Interactions between several tumor necrosis factor (TNF)-TNF receptor (TNFR) superfamily members that are expressed by T cells and NK cells and various other cell typesmodulate immune responses. This review summarizes the current understanding of how the TNF ligand-TNFR interactions 4-1BBL with 4-1B...

Full description

Bibliographic Details
Main Author:	Isabel eBarao
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2013-01-01
Series:	Frontiers in Immunology
Subjects:	Leukemia therapy NK 4-1BB GITR
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fimmu.2012.00402/full

Similar Items

Atypical TNF-TNFR superfamily binding interface in the GITR-GITRL complex for T cell activation
by: Min Zhao, et al.
Published: (2021-09-01)

Immunoprofiling of 4-1BB Expression Predicts Outcome in Chronic Lymphocytic Leukemia (CLL)
by: Kübra Kaban, et al.
Published: (2021-11-01)

Fundamental Characterization of Antibody Fusion-Single-Chain TNF Recombinant Proteins Directed against Costimulatory TNF Receptors Expressed by T-Lymphocytes
by: Hodaka Nagai, et al.
Published: (2023-06-01)

Glucocorticoid-induced TNF receptor family related protein ligand [GITR-L] is requisite for optimal functioning of regulatory CD4+ T cells.
by: Gongxian eLiao, et al.
Published: (2014-02-01)

Galectin-3 Decreases 4-1BBL Bioactivity by Crosslinking Soluble and Membrane Expressed 4-1BB
by: Morten Aagaard Nielsen, et al.
Published: (2022-06-01)

CD28 is superior to 4-1BB costimulation in generating CAR-NK cells for tumor immunotherapy
by: Pengchao Zhang, et al.
Published: (2025-03-01)

GITR ligand fusion protein agonist enhances the tumor antigen–specific CD8 T-cell response and leads to long-lasting memory
by: Nick M. Durham, et al.
Published: (2017-06-01)

Expansion of CD4+CD25-GITR+ regulatory T-cell subset in the peripheral blood of patients with primary Sjögren's syndrome: correlation with disease activity
by: R. Gerli, et al.
Published: (2012-12-01)

GITR Promotes the Polarization of TFH-Like Cells in Helicobacter pylori-Positive Gastritis
by: Siqi Ming, et al.
Published: (2021-09-01)

MEDI1873, a potent, stabilized hexameric agonist of human GITR with regulatory T-cell targeting potential
by: Natalie J. Tigue, et al.
Published: (2017-03-01)

Anti-glucocorticoid-induced Tumor Necrosis Factor–Related Protein (GITR) Therapy Overcomes Radiation-Induced Treg Immunosuppression and Drives Abscopal Effects
by: Jonathan E. Schoenhals, et al.
Published: (2018-09-01)

The intracellular portion of GITR enhances NGF-promoted neurite growth through an inverse modulation of Erk and NF-κB signalling
by: Laura McKelvey, et al.
Published: (2012-08-01)

In vivo fluctuation of Tax, Foxp3, CTLA-4, and GITR mRNA expression in CD4+CD25+ T cells of patients with human T-lymphotropic virus type 1-associated myelopathy
by: E. Ramirez, et al.
Published: (2010-11-01)

GITR and TIGIT immunotherapy provokes divergent multicellular responses in the tumor microenvironment of gastrointestinal cancers
by: Anuja Sathe, et al.
Published: (2023-11-01)

Combination with Toll-like receptor 4 (TLR4) agonist reverses GITR agonism mediated M2 polarization of macrophage in Hepatocellular carcinoma
by: Caixu Pan, et al.
Published: (2022-12-01)

The Role of GITR/GITRL Interaction in Autoimmune Diseases
by: Jie Tian, et al.
Published: (2020-10-01)

CD4+ T Cell Fate Decisions Are Stochastic, Precede Cell Division, Depend on GITR Co-Stimulation, and Are Associated With Uropodium Development
by: Stephen P. Cobbold, et al.
Published: (2018-06-01)

OCULAR INJURIES CAUSED BY BB GUN
by: M.S. Farahvash
Published: (1999-08-01)

Structures of mouse and human GITR–GITRL complexes reveal unique TNF superfamily interactions
by: Feng Wang, et al.
Published: (2021-03-01)

Peritumoral administration of DRibbles-pulsed antigen-presenting cells enhances the antitumor efficacy of anti-GITR and anti-PD-1 antibodies via an antigen presenting independent mechanism
by: Jaina M. Patel, et al.
Published: (2019-11-01)

Agonist anti-GITR antibody significantly enhances the therapeutic efficacy of Listeria monocytogenes-based immunotherapy
by: Rajeev Shrimali, et al.
Published: (2017-08-01)

The emerging landscape of novel 4-1BB (CD137) agonistic drugs for cancer immunotherapy
by: Christina Claus, et al.
Published: (2023-12-01)

GITR-GITRL System, A Novel Player in Shock and Inflammation
by: Ludovic Tibor Krausz, et al.
Published: (2007-01-01)

Analysis of 4-1BB ligand (4-1BBL)-deficient mice and of mice lacking both 4-1BBL and CD28 reveals a role for 4-1BBL in skin allograft rejection and in the cytotoxic T cell response to influenza virus.
by: DeBenedette, M, et al.
Published: (1999)

Development of a fully human anti‐GITR antibody with potent antitumor activity using H2L2 mice
by: Qiuli Tong, et al.
Published: (2022-08-01)

4-1BB: A promising target for cancer immunotherapy
by: Alyssa Min Jung Kim, et al.
Published: (2022-09-01)

Targeting 4-1BB for tumor immunotherapy from bench to bedside
by: Ya-Tao Wang, et al.
Published: (2022-09-01)

Exploring Synergy in Combinations of Tumor-Derived Vaccines That Harbor 4-1BBL, OX40L, and GM-CSF
by: Andrea J. Manrique-Rincón, et al.
Published: (2017-09-01)

Immune сheckpoints in the context of external genital endometriosis
by: A. S. Belevich, et al.
Published: (2025-03-01)

Anti-CD166/4-1BB chimeric antigen receptor T cell therapy for the treatment of osteosarcoma
by: Yitian Wang, et al.
Published: (2019-04-01)

Therapeutic vaccination with 4–1BB co-stimulation eradicates mouse acute myeloid leukemia
by: Daniel Kerage, et al.
Published: (2018-10-01)

An Fc-inert PD-L1×4-1BB bispecific antibody mediates potent anti-tumor immunity in mice by combining checkpoint inhibition and conditional 4-1BB co-stimulation
by: Alexander Muik, et al.
Published: (2022-12-01)

<i>N</i>-Glycosylation Facilitates 4-1BB Membrane Localization by Avoiding Its Multimerization
by: Ruoxuan Sun, et al.
Published: (2022-01-01)

Anti-GD2/4-1BB chimeric antigen receptor T cell therapy for the treatment of Chinese melanoma patients
by: Jiayi Yu, et al.
Published: (2018-01-01)

Agonism of 4-1BB for immune therapy: a perspective on possibilities and complications
by: Shahram Salek-Ardakani, et al.
Published: (2023-08-01)

A humanized anti-MSLN×4-1BB bispecific antibody exhibits potent antitumour activity through 4-1BB signaling activation and fc function without systemic toxicity
by: Da-yan Zhang, et al.
Published: (2025-01-01)

Macrophage STING signaling promotes NK cell to suppress colorectal cancer liver metastasis via 4-1BBL/4-1BB co-stimulation
by: Zheng Liu, et al.
Published: (2023-03-01)

Blocking the GITR-GITRL pathway to overcome resistance to therapy in sarcomatoid malignant pleural mesothelioma
by: Meilin Chan, et al.
Published: (2021-07-01)

Involvement of the 4-1BB/4-1BBL pathway in control of monocyte numbers by invariant NKT cells.
by: Cole, S, et al.
Published: (2014)

Blockade of 4-1BB and 4-1BBL Interaction Reduces Obesity-Induced Skeletal Muscle Inflammation
by: Ngoc Hoan Le, et al.
Published: (2013-01-01)